Jane Street’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,900
Closed -$98.8K 11888
2026
Q1
$98.8K Sell
11,900
-39,700
-77% -$411K ﹤0.01% 10662
2025
Q4
$638K Buy
51,600
+200
+0.4% +$2.14K ﹤0.01% 7153
2025
Q3
$453K Buy
51,400
+27,900
+119% +$217K ﹤0.01% 8069
2025
Q2
$150K Buy
+23,500
New +$134K ﹤0.01% 8748
2024
Q3
Sell
-29,800
Closed -$203K 9731
2024
Q2
$203K Buy
+29,800
New +$128K ﹤0.01% 8362
2023
Q3
Sell
-22,100
Closed -$162K 8791
2023
Q2
$162K Buy
+22,100
New +$205K ﹤0.01% 7769
2023
Q1
Sell
-11,300
Closed -$133K 9220
2022
Q4
$133K Sell
11,300
-6,100
-35% -$94.4K ﹤0.01% 7939
2022
Q3
$365K Buy
17,400
+10,500
+152% +$292K ﹤0.01% 7247
2022
Q2
$214K Sell
6,900
-8,600
-55% -$294K ﹤0.01% 8094
2022
Q1
$636K Sell
15,500
-7,500
-33% -$331K ﹤0.01% 7022
2021
Q4
$1M Buy
23,000
+6,500
+39% +$294K ﹤0.01% 5891
2021
Q3
$826K Sell
16,500
-15,500
-48% -$939K ﹤0.01% 6292
2021
Q2
$2.02M Buy
32,000
+15,200
+90% +$977K ﹤0.01% 4322
2021
Q1
$1.56M Sell
16,800
-18,100
-52% -$1.85M ﹤0.01% 4508
2020
Q4
$3.13M Buy
34,900
+32,600
+1,417% +$2.99M ﹤0.01% 2763
2020
Q3
$238K Buy
+2,300
New +$248K ﹤0.01% 6206

Other funds holding EBS

Jane Street's EBS Position: Q2 2026 in Review

Jane Street sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 117,315 shares — an estimated $982K sold.

Jane Street first reported a position in EBS in Q3 2013 and held it in 28 quarters. The position peaked at $4.89M in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Jane Street reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 117,315 Emergent Biosolutions shares in Q2 2026, an estimated $982K.
  • Jane Street first reported a position in Emergent Biosolutions in Q3 2013 and held it in 28 quarters.
  • Jane Street's Emergent Biosolutions position peaked at $4.89M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.